Back
ARK Innovation ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
59
ARKK
ARK Innovation ETF
Last Price:
45.80
Seasonality Move:
-5.69%
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
39.81
Seasonality Move:
-5.11%
Buy
59
ARK Innovation ETF (ARKK)
is a Buy
Is ARK Innovation ETF a Buy, Sell or Hold?
- The current ARK Innovation ETF [ARKK] share price is $45.19. The Score for ARKK is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ARKK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $38.88. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARKK Stock Price Chart
What is ARK Innovation ETF's stock price today?
-
The ARK Innovation ETF share price today is $45.19
The current trend is moderately bearish and ARKK is experiencing slight selling pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $38.88
The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
ARKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.49 | Buy |
Relative Strength Index (14 RSI): | 46.61 | Sell |
Chaikin Money Flow: | -2002151 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.89 - 47.31) | Sell |
Bollinger Bands (100): | (43.5 - 48.42) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 50.1 | Buy |
Chaikin Money Flow: | 536240 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.59 - 39.97) | Buy |
Bollinger Bands (100): | (38.43 - 54.53) | Sell |
ARKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.04 | Sell |
20-day SMA: | 46.16 | Sell |
50-day SMA: | 44.93 | Buy |
200-day SMA: | 45.79 | Sell |
8-day EMA: | 46.37 | Sell |
20-day EMA: | 46.11 | Sell |
50-day EMA: | 45.55 | Sell |
200-day EMA: | 45.47 | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.35 | Buy |
20-day SMA: | 38 | Buy |
50-day SMA: | 39.79 | Sell |
200-day SMA: | 52.12 | Sell |
8-day EMA: | 38.1 | Buy |
20-day EMA: | 38.47 | Buy |
50-day EMA: | 40.79 | Sell |
200-day EMA: | 49.63 | Sell |
ARK Innovation ETF Earnings Growth & ARKK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.27 per share, an increase this year of $3.51 per share, and an increase next year of $1.98 per share.
ARK Innovation ETF Technical Analysis
Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |